Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A Review
Authors:
- 23 December 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 19 (10) , 765-781
Abstract
Anticancer agents play a vital role in the cure of patients suffering from malignancy. Though, the chemotherapeutic agents are associated with various adverse effects which produce significant toxic symptoms in the patients. But this therapy affects both the malignant and normal cells and leads to constricted therapeutic index of antimalignant drugs which adversely impacts the quality of patients’ life. Due to these adversities, sufficient dose of drug is not delivered to patients leading to delay in treatment or improper treatment. Chemoprotective agents have been developed either to minimize or to mitigate the toxicity allied with chemotherapeutic agents. Without any concession in the therapeutic efficacy of anticancer drugs, they provide organ specific guard to normal tissues.Keywords
This publication has 163 references indexed in Scilit:
- Role of Glutathione in Cancer Progression and ChemoresistanceOxidative Medicine and Cellular Longevity, 2013
- Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin‐secreting BRIN‐BD11 cellsBritish Journal of Pharmacology, 2010
- Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancerCancer Chemotherapy and Pharmacology, 2010
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- Structural requirements for the cytoprotective actions of mono‐unsaturated fatty acids in the pancreatic β‐cell line, BRIN‐BD11British Journal of Pharmacology, 2008
- T-cadherin Supports Angiogenesis and Adiponectin Association with the Vasculature in a Mouse Mammary Tumor ModelCancer Research, 2008
- Brick by brick: metabolism and tumor cell growthCurrent Opinion in Genetics & Development, 2008
- HIF-1α induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemiaJournal of Molecular and Cellular Cardiology, 2007
- The biology of VEGF and its receptorsNature Medicine, 2003
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995